FRI0127 Using epidemiological registry data to provide background rate context for adverse events in a rheumatoid arthritis drug development program - a coordinated approach

Abstract

BackgroundObservational studies may provide context for adverse events observed in clinical trial programs, particularly for infrequent events or potential long-term risks. For such purposes, however, published observational data often have...